Evidence map›Paper›PMID 34685023›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Resveratrol-Loaded Levan Nanoparticles Produced by Electrohydrodynamic Atomization Technique.

Ezgi Cinan, Sumeyye Cesur, Merve Erginer Haskoylu, Oguzhan Gunduz, Ebru Toksoy Oner

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ezgi CinanIndustrial Biotechnology and System Biology (IBSB) Research Group, Department of Bioengineering, Marmara University, Istanbul 34722, Turkey.ORCID 0000-0003-3459-3484
Sumeyye CesurCenter for Nanotechnology & Biomaterials Application and Research (NBUAM), Marmara University, Istanbul 34722, Turkey.
Merve Erginer HaskoyluIndustrial Biotechnology and System Biology (IBSB) Research Group, Department of Bioengineering, Marmara University, Istanbul 34722, Turkey.
Oguzhan GunduzCenter for Nanotechnology & Biomaterials Application and Research (NBUAM), Marmara University, Istanbul 34722, Turkey.ORCID 0000-0002-9427-7574
Ebru Toksoy OnerIndustrial Biotechnology and System Biology (IBSB) Research Group, Department of Bioengineering, Marmara University, Istanbul 34722, Turkey.ORCID 0000-0001-6054-8842
Marmara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering the significant advances in nanostructured systems in various biomedical applications and the escalating need for levan-based nanoparticles as delivery systems, this study aimed to fabricate levan nanoparticles by the electrohydrodynamic atomization (EHDA) technique. The hydrolyzed derivative of levan polysaccharide from

Indexed as

drug delivery systemselectrohydrodynamic atomizationHalomonas levanpolymeric nanoparticlesresveratrol

Identifiers

PMID34685023
PMCPMC8540966
OpenAlexW3202975801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.